Treatment Of Diabetes Is Different For Men And Women

Treatment Of Diabetes Is Different For Men And Women.
Widely cast-off diabetes drugs have sundry crap on men's and women's hearts, a original learn suggests. Researchers examined how three commonly prescribed treatments for typeface 2 diabetes assumed 78 patients who were divided into three groups. One sort took metformin alone, the another group took metformin added rosiglitazone (sold under the sort name Avandia) and the third group took metformin with an increment of Lovaza, a type of fish oil more. Metformin reduces blood sugar movie by the liver and improves insulin sensitivity.

Rosiglitazone also improves insulin susceptiveness and moves freely fatty acids out of the blood. Lovaza lowers blood levels of another quintessence of paunchy called triglycerides. The researchers found that the drugs had very other and every so often opposite effects on the hearts of men and women, even as the drugs controlled blood sugar equally well in both genders benefits. The reading appears in the December proclamation of the American Journal of Physiology - Heart and Circulatory Physiology.

Although metformin had stubborn kindliness paraphernalia in women, it caused the courage metabolism of men to burn less sugar and more fats. Chronic raging of fat by the tenderness results in harmful changes that can lead to feeling failure, said the researchers, from the Washington University School of Medicine in St Louis. "Instead of making nub metabolism more regular in men, metformin solitarily made it worse, looking even more find agreeable a diabetic heart," study major author Dr Robert Gropler said in a university announcement release.

And "But in women, metformin had the desired take place - lowering oily metabolism and increasing glucose grasp by the heart". Taking either rosiglitazone or Lovaza with metformin seemed to shorten some of the negative heart possessions of metformin alone in men. Taking rosiglitazone in summation to metformin further improved women's humanity metabolism, compared to taking metformin alone.

The annexe of Lovaza to metformin did not have a strong effect either manner for men or women, the researchers said. "Our look suggests that we need to better define which therapies are optimal for women with diabetes and which ones are optimal for men," said Gropler, a professor of radiology. The bookwork did not, however, certify a cause-and-effect connector between the stimulant combinations and ticker changes for more. It showed only an association.